Why ACE—overview of the development of the subtype-selective histone deacetylase inhibitor chidamide in hormone receptor positive advanced breast cancer
@article{TBCR37836, author = {Zhiqiang Ning}, title = {Why ACE—overview of the development of the subtype-selective histone deacetylase inhibitor chidamide in hormone receptor positive advanced breast cancer}, journal = {Translational Breast Cancer Research}, volume = {1}, number = {0}, year = {2020}, keywords = {}, abstract = {}, issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/37836} }